SBIR/STTR Research Award

Cyclic Flow Cytometry for Ultra-High Marker Single-Cell Analysis

Award identifier 7fa1fbb092f81589d173fc147359bbfd8b37e88add9ae15a3f03f14ebd7ac401Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,710,620

Program and phase

SBIR · Phase II

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
LASE INNOVATION INC
Proposal award date
2021-09-08
Contract end date
2023-08-31
UEI
LQDAZMN14NM7
Solicitation number
PA20-260
Topic code
400

Research abstract

Abstract Quantifying the presence, function, and fate of different immune cells is crucial in immunology research and development of immunotherapies. Flow cytometry is a single-cell technique that is widely used to measure different protein markers expressed by immune cells at high throughput. However, spectral overlap between fluorophore labels makes measurement of more than 20 markers difficult, often requiring months of optimization, and limits the maximum number of markers measured to around 40. These limitations prevent more comprehensive characterization of immune cells that is critically needed for immunology and immune-oncology research. Mass cytometry and RNA-seq based methods are throughput-limited and cost-prohibitive for measuring patient blood samples containing millions of cells. The goal of this SBIR application is to develop cyclic flow cytometry, a high-throughput, affordable and easy-to-use solution for the high-marker single-cell analysis market. Cyclic flow cytometry leverages proprietary laser particle technology to barcode individual cells for repeated flow measurements, enabling complex flow cytometry experiments with 30 or more markers to be broken down into multiple, much easier cycles with around 10 markers at a time. The feasibility of this innovative approach has been verified in the Phase I research. The specific aims of this Phase II research involve developing and testing a complete workflow and fully functional prototype for cyclic flow cytometry. The system will be validated with external investigators for several applications. Completion of the Phase II work will lead to early market validation of cyclic flow cytometry and directly lead to design of product-ready prototypes, followed by commercial launch.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

6 SBIR/STTR records share this UEI (2020–2025). Reported award amounts total $5,194,935. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.